Physician profile
Ken Tatebe
NPI 1942620745
$42,417.84
in general payments reported to CMS, 2019-2025
10 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $70.14 · 2021: $4,839 · 2022: $737 · 2023: $7,985 · 2024: $12K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $6,986 · Honoraria: $6,958 · Food and Beverage: $5,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,125.00 |
| Travel and Lodging | $6,985.66 |
| Honoraria | $6,957.50 |
| Food and Beverage | $5,126.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $27,601.57 | 2022-2025 | Gammatile, Gammatile |
| Novocure INC. | $13,081.71 | 2019-2025 | Optune |
| Icotec Medical INC. | $850.02 | 2024-2025 | Icotec Blackarmor Spine System, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Brainlab, INC. | $352.81 | 2019 | |
| Siemens Medical Solutions USA, INC. | $207.98 | 2024-2025 | Bravos Afterloader System |
| Menarini Silicon Biosystems, INC. | $128.11 | 2025 | |
| Ge Healthcare | $89.42 | 2022 | |
| Acell, INC. | $55.77 | 2019 | |
| Jazz Pharmaceuticals INC. | $30.76 | 2025 | |
| Elekta, INC. | $19.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Tatebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.